scispace - formally typeset
S

Simon Young

Researcher at University of Texas Health Science Center at Houston

Publications -  67
Citations -  4203

Simon Young is an academic researcher from University of Texas Health Science Center at Houston. The author has contributed to research in topics: Bone regeneration & Medicine. The author has an hindex of 23, co-authored 57 publications receiving 3486 citations. Previous affiliations of Simon Young include University of Texas System & Harvard University.

Papers
More filters
Journal ArticleDOI

Gelatin as a delivery vehicle for the controlled release of bioactive molecules.

TL;DR: This review will emphasize how biomolecules released from gelatin controlled-release systems are able to retain their biological activity, allowing for their use in tissue engineering, therapeutic angiogenesis, gene therapy, and drug delivery applications.
Journal ArticleDOI

Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model

TL;DR: The results indicate that delivery of both growth factors may enhance bone bridging and union of the critical size defect compared to delivery of BMP-2 alone and suggests an interplay between these growth factors for early bone regeneration.
Journal ArticleDOI

Evaluation of bone regeneration using the rat critical size calvarial defect.

TL;DR: The protocol for one such model, the rat calvarial defect, is described, which allows for evaluation of biomaterials and bone tissue engineering approaches within a reproducible, non-load-bearing orthotopic site.
Journal ArticleDOI

Injectable biomaterials for regenerating complex craniofacial tissues.

TL;DR: In this review, injectable materials that form scaffolds or networks capable of both replacing tissue function early after delivery and supporting tissue regeneration over a time period of weeks to months are examined.
Journal ArticleDOI

Dose Effect of Dual Delivery of Vascular Endothelial Growth Factor and Bone Morphogenetic Protein-2 on Bone Regeneration in a Rat Critical-Size Defect Model

TL;DR: The dose effect of dual delivery of vascular endothelial growth factor (VEGF) and bone morphogenetic protein-2 (BMP-2) on bone regeneration was investigated in a rat cranial critical-size defect and the addition of VEGF was unable to reverse this decrease in PBF, although improvements in the number of bridged defects did occur in some groups.